News

Anixa secures USPTO patent for its breast cancer vaccine using α-lactalbumin, enhancing its IP portfolio and expanding future ...
The patent includes broad claims related to methods of eliciting an immune response targeting the Anti-Mullerian Hormone Receptor, Type II (AMHR2), a target for ovarian cancer prevention and ...
AMH (Anti-Müllerian hormone) is a hormone that is secreted by specialised granulosa cells in ovarian follicles. It is produced by small follicles with a diameter of less than 4 millimetre in a ...
“Had I known earlier, I think I would have made different decisions that would have benefited me very differently now.” Kelly ...